Diabetes Treatment Tied to Lower Uterine Fibroid Incidence in Midlife Women, Study Finds Medha Baranwal25 Oct 2024 8:15 AM ISTUSA: A recent study from the Study of Women's Health Across the Nation (SWAN) has shed light on the relationship between diabetes, insulin resistance,...
Higher Satisfaction with Once-Weekly Insulin Icodec Compared to Daily Doses in Type 2 Diabetes: ONWARDS Trials Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: A recent analysis from the ONWARDS clinical trials has revealed significant improvements in treatment satisfaction among individuals with Type 2...
Need to Remove Existing Barriers for Effective Weight Loss? Study Provides Insights Dr. Bhumika Maikhuri24 Oct 2024 8:00 AM ISTExpanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a...
Diabetic kidney disease: Research identifies Cause and possible therapeutic approach Dr. Kamal Kant Kohli24 Oct 2024 6:15 AM ISTDiabetic kidney disease-a complication of diabetes-is considered the leading cause of chronic kidney disease and kidney failure worldwide. It is...
Melatonin Supplementation Improves Glycemic Control in Type 2 Diabetes, Research Finds Medha Baranwal23 Oct 2024 8:45 AM ISTIran: A recent systematic review and meta-analysis have highlighted the potential benefits of melatonin supplementation for individuals with Type 2...
SOUL Trial Shows 14% Reduction in Cardiovascular Events with Oral Semaglutide in Type 2 Diabetes Dr. Bhumika Maikhuri23 Oct 2024 8:15 AM ISTThe SOUL cardiovascular outcomes trial was a double-blinded, randomised trial that compared oral semaglutide to placebo as an adjunct to standard of...
Nearly 19 per cent of Jammu population Diabetic, reveals ICMR-led study Kajal Rajput22 Oct 2024 5:00 PM ISTSrinagar: Union Minister Dr Jitendra Singh, who is also a nationally renowned Diabetologist recently released the Jammu-related data of the 'first of...
Oral semaglutide cuts MACE risk by 14% in adults with type 2 diabetes: SOUL trial Dr. Kamal Kant Kohli22 Oct 2024 9:30 AM ISTAccording to new data from the SOUL trial Oral semaglutide reduced MACE by 14% in Type 2 Diabetes patients. Novo Nordisk will present more detailed...
Metformin Improves CVD Markers in PCOS: Latest 2024 Research Update Dr. Kamal Kant Kohli22 Oct 2024 9:15 AM ISTMetformin decreases carotid intima-media thickness (CIMT) and improves flow-mediated dilation (FMD) in patients with polycystic ovary syndrome (PCOS),...
What are advancements and best practices for management of diabetic foot complications? Medha Baranwal22 Oct 2024 8:45 AM ISTIndia: As diabetes rates rise globally, diabetic foot care has become a vital focus in healthcare. A recent review published in Diabetes Research and...
Modified Insulin with On-Off Switch May Prevent Sudden Hypoglycemic Episodes in Diabetics: Study Finds Dr. Bhumika Maikhuri22 Oct 2024 8:00 AM ISTModified insulin that can prevent sudden drops in blood sugar has been demonstrated in laboratory experiments and animal models, reports a paper in...
Empagliflozin and Topiramate combo Effective for Weight Loss in Non-Diabetic Overweight Individuals: Study Medha Baranwal21 Oct 2024 8:15 AM ISTIran: A recent randomized study revealed that the combination of empagliflozin (EMPA) and topiramate (TPM) alongside calorie restriction resulted in a...
